Target intelligence / Profile preview

RNA, U6 small nuclear 260, pseudogene (RNU6-260P)

Target: RNU6-260P
Molecular classification: Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene

Overview

RNA, U6 small nuclear 260, pseudogene (RNU6-260P) is a human gene classified as a pseudogene for a small nuclear RNA (snRNA) involved in the spliceosome complex. However, as a pseudogene, RNU6-260P does not encode a functional RNA or protein product and is not known to have a biological or pathological function in humans[1][7]. It is not considered a therapeutic target.

Other names: RNU6-260P

Beyond the preview

Go deeper on RNA, U6 small nuclear 260, pseudogene (RNU6-260P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 260, pseudogene (RNU6-260P).

Explore the full profile